Denny’s Dish: Unveiling Our Delicious Q4 & Full-Year 2024 Results: A Savor-Worthy Read!

Denny’s Corporation: Q4 and Full Year 2024 Financial Results and Business Update In a recent press release, Denny’s Corporation shared their financial results for the fourth quarter and full year that ended on December 25, 2024. Let’s delve into the details. Financial Highlights For the fourth quarter, Denny’s Corporation reported a revenue of $542.1 million,…

Read More

Kenai Therapeutics Expands Research Operations: New Facility at Lilly Gateway Labs

Kenai Therapeutics Establishes Research Facilities in San Diego to Advance Neuron Replacement Therapies San Diego, CA – Kenai Therapeutics, a pioneering biotechnology company, has recently announced the establishment of its research and laboratory facilities at Lilly Gateway Labs (Gateway Labs) in San Diego. This move comes as part of a strategic partnership with Alexandria Real…

Read More

Altair Unveils Plans for FutureIndustry 2025 Global Event: A Look Ahead to the Future of Technology and Innovation

Future.Industry 2025: A Virtual Gathering of Thought Leaders and Industry Experts Altair, a global leader in computational intelligence, is set to host its annual flagship event, Future.Industry 2025. This year, the event will be held virtually on March 5-6, 2025. Despite the shift to a virtual format, the company promises an engaging and thought-provoking experience…

Read More

Orchard Therapeutics’ New CCO and Exciting Business Updates: Robin Kenselaar Takes the Commercial Reins for Their Gene Therapy for MLD

Lenmeldy™: The Game-Changer in Gene Therapy, Making Waves in the US Have you heard about Lenmeldy™, the latest breakthrough in gene therapy? This revolutionary treatment, also known as atidarsagene autotemcel, has recently started making heads turn in the US as the first patients are being treated in a commercial setting. A Leap Forward in Medical…

Read More